News & Views

12th September 2017

Montreux Capital Management Nominated for Prestigious LaingBuisson “Investor of the Year” Award, whilst The Regard Group is nominated in the Supported Living Category

Montreux Capital Management (UK) (MCM UK) has been nominated for “Investor of the Year” at the prestigious LaingBuisson Awards. The award, given to the very best investors in the industry is drawn from across the whole Healthcare sector. Those shortlisted have demonstrated to the judges a well-executed investment strategy and significant return on capital employed for their investors.

MCM (UK) is amongst prestigious company having been nominated alongside Octopus Group and Cheyne Capital. The award sets the Montreux Healthcare Fund’s return against other participants in the healthcare space and benchmarks the Fund’s successful performance against other leaders in the market.

The Regard Group, the Montreux Healthcare Fund’s Operating Company, was also nominated in the Supported Living category, adding another award nomination to an already successful season for the Group.

Oliver Harris, CEO of Montreux Capital Management (UK), stated: “We are incredibly pleased to be nominated for Investor of the Year. This award carries a lot of weight in the healthcare space as LaingBuisson are widely regarded as the best analysts in the industry. It is a great accolade and a worthy reward for the MCM UK team. We are also pleased to see that Regard has again been recognised as one of the best Supported Living providers in the UK. Of course, we are hopeful that both MCM UK and Regard are successful. I certainly think we would both be worthy winners”.

Disclaimer

The information on this site is intended only for the use of Independent Financial Advisors (IFAs) and other professionally recognised financial intermediaries & institutions.. Should you proceed to access this site, you will be representing and warranting that you are an IFA or other professionally recognised financial intermediary . What follows is not an offer or invitation to acquire an investment and should therefore not be relied upon by, any person in any jurisdiction where such an offer or invitation would be unlawful. Persons in respect of whom such prohibitions apply must not access this web site. None of the information contained on this site constitutes personal recommendations nor advice. Product details should always be read in conjunction with the appropriate offering documents. An application for any of the investment products on this page should be made having fully read not only the relevant application form, but also the relevant terms and conditions and offering documents. If you are unsure about the meaning of any information provided on this web page, then please consult your financial or other professional adviser. We do not offer investment advice.

This web site may contain or be linked to advice or statements of third parties. We make no representation as to the accuracy, completeness, timeliness or suitability of such information, and we have not and will not review or update such information and caution you that any use made of such information is at your own risk. Some of the information contained on this web site may also have been prepared or provided by third parties and may not have been verified by us. We hereby exclude any liability arising out of any preparation or provision of such information for the web site and makes no warranty as to the accuracy, suitability or completeness of any such information.

I agree, Continue

Information on this webpage relates to and is provided by Montreux Capital Management (UK) Limited

The content of this webpage should not be construed as financial advice. Any decision to invest should be made only on the basis of the relevant documentation for each investment. Past performance is not necessarily a guide to future performance. The value of an investment may go down as well as up and investors may not get back the full amount invested. Investments in small unquoted companies carry an above-average level of risk. These investments are highly illiquid and as such, there may not be a readily available market to sell such an investment. Montreux Capital Management (UK) Limited and Sapia Partners LLP (together "the Sponsors," or "Sponsor) do not provide specific individual advice on the suitability of investments with regard to a potential investor's individual circumstances, risk tolerance or investment objectives and investors should seek independent financial advice if they are in any doubt whether a product is suitable for them.

Montreux Capital Management (UK) Limited is an Appointed Representative of Sapia Partners LLP which is authorised and regulated by the Financial Conduct Authority.

I agree, Continue